These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9168248)

  • 1. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal.
    Sayre LM; Zagorski MG; Surewicz WK; Krafft GA; Perry G
    Chem Res Toxicol; 1997 May; 10(5):518-26. PubMed ID: 9168248
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid deposition in Alzheimer's disease.
    Meena-Leist CE; Parker JC
    Ann Clin Lab Sci; 1993; 23(3):173-7. PubMed ID: 8323250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.
    Atwood CS; Huang X; Moir RD; Tanzi RE; Bush AI
    Met Ions Biol Syst; 1999; 36():309-64. PubMed ID: 10093929
    [No Abstract]   [Full Text] [Related]  

  • 5. beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Butterfield DA
    Chem Res Toxicol; 1997 May; 10(5):495-506. PubMed ID: 9168246
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurotoxicity of Alzheimer's beta-amyloid protein and membrane lipids].
    Kawahara M; Kuroda Y
    Tanpakushitsu Kakusan Koso; 1999 Oct; 44(13):1982-7. PubMed ID: 10517107
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease.
    Irie K; Murakami K; Masuda Y; Morimoto A; Ohigashi H; Ohashi R; Takegoshi K; Nagao M; Shimizu T; Shirasawa T
    J Biosci Bioeng; 2005 May; 99(5):437-47. PubMed ID: 16233815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease.
    Ricciarelli R; D'Abramo C; Zingg JM; Giliberto L; Markesbery W; Azzi A; Marinari UM; Pronzato MA; Tabaton M
    Free Radic Biol Med; 2004 Apr; 36(8):1018-24. PubMed ID: 15059642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of intracellular A beta in Alzheimer's disease].
    Tabira T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):175-80. PubMed ID: 12451689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogen: regulation of amyloid-beta protein metabolism and attenuation of amyloid-beta protein neurotoxicity].
    Zhang S; Yao T
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):197-201. PubMed ID: 14628462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alzheimer's disease: advance in researches on Beta-amyloid protein].
    Liu J; Bao Y; An L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):371-4. PubMed ID: 12856622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free radicals as mediators of toxicity in Alzheimer's disease: a review and hypothesis.
    Tabet N; Mantle D; Orrell M
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):127-52. PubMed ID: 10967748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid, aluminium and the aetiology of Alzheimer's disease.
    Walton JR
    Med J Aust; 1996 Mar; 164(6):382-3. PubMed ID: 8606673
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Klunk WE; Mathis CA; Price JC; Lopresti BJ; DeKosky ST
    Brain; 2006 Nov; 129(Pt 11):2805-7. PubMed ID: 17071918
    [No Abstract]   [Full Text] [Related]  

  • 17. [The mechanisms of pathogenesis in Alzheimer's disease].
    Li L
    Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):345-8. PubMed ID: 12501666
    [No Abstract]   [Full Text] [Related]  

  • 18. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME; Gouras G; Relkin NR; Szabo P
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free radical reactions of methionine in peptides: mechanisms relevant to beta-amyloid oxidation and Alzheimer's disease.
    Schöneich C; Pogocki D; Hug GL; Bobrowski K
    J Am Chem Soc; 2003 Nov; 125(45):13700-13. PubMed ID: 14599209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of Alzheimer's Abeta peptide: the many roads to perdition.
    Tanzi RE; Moir RD; Wagner SL
    Neuron; 2004 Sep; 43(5):605-8. PubMed ID: 15339642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.